Widely used for the management of high blood pressure, arrhythmias, angina pectoris and other conditions, calcium channel blocking drugs can cause a wide range of adverse effects including constipation, dizziness, rapid heartbeat, extreme tiredness, flushing, headache, nausea, and swelling of the feet and lower legs.
A scientific study conducted at the Dr. Rath Research Institute reveals that this class of drugs can also lead to reduced levels of vitamin C inside the body’s cells. This finding explains the reason for the increased risk of heart disease, breast cancer, and gum disease reported with these drugs, as vitamin C plays an essential role in preventing these diseases.
Far from limiting the use of calcium channel blocking drugs, however, conventional medicine is instead seeking to find new uses for them. A recent claim is that they supposedly stop the spread of cancer. Ultimately, of course, this illustrates one of the key strategies of the pharmaceutical ‘business with disease.’ Towards expanding their markets drug companies are continuously looking for new applications for existing medications, particularly when their patents have expired. Promoting the painkiller aspirin under the illusion that it will prevent heart attacks is one of the classic examples of this.
To learn how glaucoma and other eye diseases can be prevented using science-based combinations of micronutrients, visit the Dr. Rath Education website.